Genetic alterations that deregulate RB and PDGFRA signaling pathways drive tumor progression in IDH2-mutant astrocytoma
Kensuke Tateishi(Yokohama City University Medical Center), Hiroaki Wakimoto(Harvard University)
Cited by 5
Related Papers
Interactions between cancer cells and immune cells drive transitions to mesenchymal-like states in glioblastoma
|Cancer Cell|2021|607
Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy
|Proceedings of the National Academy of Sciences|2009|454
Human Glioblastoma–Derived Cancer Stem Cells: Establishment of Invasive Glioma Models and Treatment with Oncolytic Herpes Simplex Virus Vectors
|Cancer Research|2009|358
Brain Tumor Cells in Circulation Are Enriched for Mesenchymal Gene Expression
|Cancer Discovery|2014|251
Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells
|Neuro-Oncology|2011|239